Trial search
search
reset
more
Public title
Scientific title
Subject ID
Registration Status
Registration number
Secondary ID
Applicant
Study leader
Year
Primary sponsor
Secondary sponsor
Source(s) of funding
Target disease
Target disease code
Study type
Study phase
Study design
Recruiting status
Execute time(From)
Execute time(END)
Sign the informed consent
Gender
Nation(Area)
Province
City
Unit (hospital)
Institution
Level of the institution
Intervention
Intervention code
Approved by ethic committee
Calculated Results after the Study Completed puboptionc access
6 trials have been registered
Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR2600120773 Orelabrutinib Combined With Rituximab and Lenalidomide (OR2 Regimen) as First-line Treatment for Marginal Zone Lymphoma: a Multicenter Prospective Single Arm Trial

The First Hospital of Jilin University

Interventional study 2026/03/19
Historical Versions ChiCTR2500104557 Risk-adapted therapeutic strategy in +1q NDMM: a prospective, multicenter study

The First Hospital of Jilin University

Observational study 2025/06/19
Historical Versions ChiCTR2500100469 A Prospective, Single-Arm Clinical Study of Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Therapy Followed by Etoposide and Cytarabine (EA) Consolidation Therapy for Primary Central Nervous System Lymphom

The First Hospital of Jilin University

Interventional study 2025/04/10
Historical Versions ChiCTR2400083174 Safety and feasibility of determining the length of postoperative hospital stay in colorectal cancer patients based on the ineffective hospital day evaluation system - a multi-centre, prospective cohort study

The First Hospital of Jilin University

Observational study 2024/04/17
Historical Versions ChiCTR2400081273 A single-arm, open label, single-center clinical study of daratumumab combined with bortezomib, and dexamethasone (DVd) regimen in the treatment of newly diagnosed patients with monoclonal gammopathy of renal significance

Army Medical University Affiliated Daping Hospital

Interventional study 2024/02/27
Historical Versions ChiCTR2300073052 Prospective, multicenter, open and non-interference observational clinical study of daratumumab, pomalidomide and dexamethasone (Dara-PD) in the treatment of patients with first relapse of multiple myeloma

The First Hospital of Jilin University

Observational study 2023/06/30